Dr. Daly's research is largely focused on novel, noninvasive techniques for the diagnosis and monitoring of cardiac allograft vasculopathy (CAV), including the development of serum biomarkers and novel imaging technologies.
Currently, he is studying the underpinnings of chronic allograft rejection—the major cause of mortality following pediatric heart transplant. Through his research, Dr. Daly aims to determine if endothelial injury and repair responses can be monitored in recipients of cardiac transplantation, and to establish if patterns of these biomarkers predict, or are associated with, the development of chronic allograft rejection. In addition, Dr. Daly's research aims to establish whether molecular imaging studies of myocardial blood flow and endothelial cell activation are associated with early CAV/chronic rejection.
About Kevin Daly
Dr. Daly received his MD from Columbia University College of Physicians & Surgeons. He completed his internship and residency at the Children’s Hospital at Montefiore (Albert Einstein College of Medicine) and his fellowship at Boston Children's Hospital.
View Dr. Daly’s publications in PubMed.